MVABEA SUSPENSION INYECTABLE

Janssen-Cilag International N.V🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 25, 2021
Approval ID: 55348d8a7bd84f31
Company: Janssen-Cilag International N.V
Type: Standard

Approval Details

Approval Id: 55348d8a7bd84f31
Drug Cima Aemps Name: MVABEA SUSPENSION INYECTABLE
Register Number: 1201445001
Holder Company Name: Janssen-Cilag International N.V
Marketing Company Name: Janssen Cilag S.A.
Holder Company Detail Path: /organization/janssen-cilag-international-nv
Authorization Date: 2021-05-25
Dosage Form: SUSPENSIÓN INYECTABLE
Dose: 0,5 ml
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Janssen-Cilag International N.V
Company Detail Path: /organization/janssen-cilag-international-nv

Active Ingredients

VACUNA DE VECTOR VACCINIA ANKARA MODIFICADO, MULTIVALENTE, VIVA, RECOMBINANTE, NO REPLICATIVO EN CELULAS HUMANAS, QUE EXPRESA LAS GLICOPROTEINAS (GP) DE LOS VIRUS DEL EBOLA MAYINGA, SUDAN GULU, MARBURGO Y MUSOKE Y NUCLOPROTEINA DEL VIRUS TAI FOREST

0,7x10e8 unidades infecciosas (Inf.U)

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 25, 2021

Approval ID

55348d8a7bd84f31

Type

Standard

Back to CIMA-AEMPS Approvals

MVABEA SUSPENSION INYECTABLE

Approval Details

Company Information

Active Ingredients

Quick Info